Exact Sciences is the manufacturer of Cologuard®, the first and only FDA approved stool DNA noninvasive colorectal cancer (CRC) screening test. Cologuard was approved by the FDA in August 2014 to screen for CRC in adults of either sex, 45 years or older, who are average risk for CRC. Cologuard® is incorporated into leading CRC screening guidelines and recommendations, and covered by a variety of health insurance plans, as well as Medicare. For more information visit www.CologuardTest.com. Rx Only.